Abstract:This study focuses on the role of bioethics in designing public healthcare policies towards elderly patients with cancer. The general overview of public administration and healthcare approach to treatment. Interpretation of how the EU public administration faces the challenges of an ageing population and extended human longevity. The significant emotional impact a genetic cancer test holds, both in the patients and their families, is to be explained. From the bioethics' perspective, artificial intelligence and… Show more
“…The interconnection of the social dimension in health, specifically elderly oncology patients, is a new medical strategy valued by political options [7]. Sequentially, we suggest the concept of "health innovation" as a change to the medical/medicine model.…”
mentioning
confidence: 91%
“…Several initiatives have been launched to ensure that governments everywhere see health as a priority within their internal policies (not only the health-related ones but also those in the economic, social, cultural, and environmental ranges). These initiatives help alert policymakers to a change of mindset, showing the urgent need to improve disease prevention and treatment, and expand policies and actions on promoting health and well-being [7].…”
mentioning
confidence: 99%
“…The social dimension in health has become a political priority with an interconnection between health policy and social policy [8]. Elderly patients with cancer need a policy on social determinants to access the best oncology hospital health care [7].…”
The article presents concepts and the Public Health Policy University of Lisbon Lab project to answer questions about the macro-environment of cancer and loneliness. Although the biomedical model has considered the disease’s general symptoms, it takes a holistic approach to incorporate several other circumstances that influence health. Emotional, social, psychological, and economic factors mirror influencing layers that affect wellness. Portugal follows Europe’s tendency and simultaneously reflects its reality. Governmental internal policies, amplified by regulations, improve disease prevention and treatment. Nevertheless, it focuses on the general population instead of on the individual. Once cancer, one of the leading causes of global death, is perceived as an isolated incident, we believe macro-environmental circumstances, and not only biological ones, must be considered. Furthermore, cancer in the elderly intensifies solicitude, and expanded policies and actions demand individual health determinants. In the Portuguese Public Health Policy, we started a collaborative Oncology, Human Kinetics, and Public Health Policy project. This is the first project of the Public Health Policy Lab from the Institute of Social and Political Sciences of the University of Lisbon. Based on a brief review of two research projects on improving cancer patients’ health, we promote micro-organisational projects to deal with the social phenomena of loneliness, physical activity, and lifestyle. As a sequence of the well-known social determinants, we endorse political determinants as the basis for public health. The latest worldwide governmental trend is to create public labs as an innovation of political policymaking. Throughout this reflection, the need for a new rational approach specially designed for a social model is considered.
“…The interconnection of the social dimension in health, specifically elderly oncology patients, is a new medical strategy valued by political options [7]. Sequentially, we suggest the concept of "health innovation" as a change to the medical/medicine model.…”
mentioning
confidence: 91%
“…Several initiatives have been launched to ensure that governments everywhere see health as a priority within their internal policies (not only the health-related ones but also those in the economic, social, cultural, and environmental ranges). These initiatives help alert policymakers to a change of mindset, showing the urgent need to improve disease prevention and treatment, and expand policies and actions on promoting health and well-being [7].…”
mentioning
confidence: 99%
“…The social dimension in health has become a political priority with an interconnection between health policy and social policy [8]. Elderly patients with cancer need a policy on social determinants to access the best oncology hospital health care [7].…”
The article presents concepts and the Public Health Policy University of Lisbon Lab project to answer questions about the macro-environment of cancer and loneliness. Although the biomedical model has considered the disease’s general symptoms, it takes a holistic approach to incorporate several other circumstances that influence health. Emotional, social, psychological, and economic factors mirror influencing layers that affect wellness. Portugal follows Europe’s tendency and simultaneously reflects its reality. Governmental internal policies, amplified by regulations, improve disease prevention and treatment. Nevertheless, it focuses on the general population instead of on the individual. Once cancer, one of the leading causes of global death, is perceived as an isolated incident, we believe macro-environmental circumstances, and not only biological ones, must be considered. Furthermore, cancer in the elderly intensifies solicitude, and expanded policies and actions demand individual health determinants. In the Portuguese Public Health Policy, we started a collaborative Oncology, Human Kinetics, and Public Health Policy project. This is the first project of the Public Health Policy Lab from the Institute of Social and Political Sciences of the University of Lisbon. Based on a brief review of two research projects on improving cancer patients’ health, we promote micro-organisational projects to deal with the social phenomena of loneliness, physical activity, and lifestyle. As a sequence of the well-known social determinants, we endorse political determinants as the basis for public health. The latest worldwide governmental trend is to create public labs as an innovation of political policymaking. Throughout this reflection, the need for a new rational approach specially designed for a social model is considered.
“…Of these deaths, almost half (46%) were in patients over 70 years of age [ 2 ]. This is likely a consequence of three main factors: (1) as the population increases, so does the annual number of deaths, (2) the world is getting wealthier and fewer people die prematurely [ 3 ], and (3) cancer is a disease of ageing: as the global population ages, the incidence and prevalence of cancer increases.…”
The number of older adults living with cancer is increasing. There is a clear lack of representation of older adults in clinical trials, including cancer trials. Reasons for this are multifactorial and complex and include protocol, patient and sponsor factors. Potential solutions to overcome issues with trial design include varied methods of recruitment with flexible inclusion criteria. Possible alternatives to randomised trials include prospective cohort studies, pragmatic trials and the use of national population-based data sets. Patient factors may be addressed by integration of geriatric assessment, so patients can be randomised or treated based on their individual needs. Additionally, standard protocols for including older adults with cognitive impairment should be developed, rather than automatic exclusion. Increased effort is needed from sponsors and governing health care bodies to make recruitment of older adults to clinical trials standard.
“…Presently, the commonly called oriented treatment is considered the most accurate. However, it doesn't consider the social condition of patients ( 10 ), although we presume everybody has equal access to the most advanced treatment. Yet, the health model used in the East is based on combating diseases and promoting health.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.